Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1

Human Brain Mapping

Volumn 35, Issue 1, 2014, Pages 89-106

  Duarte, João V ^a   Ribeiro, Maria J ^a   Violante, Inês R ^a   Cunha, Gil ^a   Silva, Eduardo ^b   Castelo Branco, Miguel ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Brain structure; MRI; Multivariate pattern classification; Neurofibromatosis type 1; Neuroimaging; Support vector machine (SVM)

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BASAL GANGLION; BRAIN; BRAIN MALFORMATION; BRAIN REGION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOLD STANDARD; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; THALAMUS; VISUAL CORTEX; VOXEL BASED MORPHOMETRY; WHITE MATTER;

BRAIN STRUCTURE; MRI; MULTIVARIATE PATTERN CLASSIFICATION; NEUROFIBROMATOSIS TYPE 1; NEUROIMAGING; SUPPORT VECTOR MACHINE (SVM);

ADULT; BRAIN; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; NEUROFIBROMATOSIS 1; PHENOTYPE; SUPPORT VECTOR MACHINES;

EID: 84889652962     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22161     Document Type: Article

References (74)

1. Ashburner J (2007): A fast diffeomorphic image registration algorithm. NeuroImage 38:95-113.
2. Ashburner J (2009): Computational anatomy with the SPM software. Magn Reson Imaging 27:1163-1174.
3. Ashburner J, Friston KJ (2000): Voxel-based morphometry-The methods. NeuroImage 11:805-821.
4. Ashburner J, Friston KJ (2005): Unified segmentation. NeuroImage 26:839-851.
5. Barbier C, Chabernaud C, Barantin L, Bertrand P, Sembely C, Sirinelli D, Castelnau P, Cottier JP (2011): Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: Correlation with T2 hyperintensities. Neuroradiology 53:141-148.
6. Benton AL, Varney NR, Hamsher KD (1978): Visuospatial judgment. A clinical test. Arch Neurol 35:364-367.
7. Billingsley RL, Schrimsher GW, Jackson EF, Slopis JM, Moore BD III (2002): Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1. Arch Neurol 59:616-622.
8. Brain Development Cooperative Group (2012): Total and regional brain volumes in a population-based normative sample from 4 to 18 years: The NIH MRI study of normal brain development. Cereb Cortex:22.
9. Bray S, Chang C, Hoeft F (2009): Applications of multivariate pattern classification analyses in developmental neuroimaging of healthy and clinical populations. Front Hum Neurosci 3:32.
10. Brown JA, Emnett RJ, White CR, Yuede CM, Conyers SB, O'Malley KL, Wozniak DF, Gutmann DH (2010): Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 19:4515-4528.
11. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ (2004): A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: Reliability and validation against manual measurement of total intracranial volume. Neuroimage 23:724-738.
12. Chang YW, Lin CJ (2008): Feature ranking using linear SVM. InJMLR: Workshop and Conference Proceedings, Hong-Kong, 3:53-64.
13. Cheon KA, Kim YS, Oh SH, Park SY, Yoon HW, Herrington J, Nair A, Koh YJ, Jang DP, Kim YB, Leventhal BL, Cho ZH, Castellanos FX, Schultz RT (2011): Involvement of the anterior thalamic radiation in boys with high functioning autism spectrum disorders: A Diffusion Tensor Imaging study. Brain Res 1417:77-86.
14. Clements-Stephens AM, Rimrodt SL, Gaur P, Cutting LE (2008): Visuospatial processing in children with neurofibromatosis type 1. Neuropsychologia 46:690-697.
15. Costa RM, Silva AJ (2003): Mouse models of neurofibromatosis type I: Bridging the GAP. Trends Mol Med 9:19-23.
16. Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ (2002): Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415:526-530.
17. Cristianini N, Shawe-Taylor J (2000): An introduction to Support Vector Machines and Other Kernel-Based Learning Methods.Cambridge: Cambridge University Press.
18. Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I, Silva AJ (2008): Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135:549-560.
19. Cutting LE, Koth CW, Burnette CP, Abrams MT, Kaufmann WE, Denckla MB (2000): Megalencephaly in NF1: Predominantly white matter contribution and mitigation by ADHD. J Child Neurol 15:157-160.
20. Cutting LE, Cooper KL, Koth CW, Mostofsky SH, Kates WR, Denckla MB, Kaufmann WE (2002): Megalencephaly in NF1: Predominantly white matter contribution and mitigation by ADHD. Neurology 59:1388-1394.
21. Daston MM, Ratner N (1992): Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development. Dev Dyn 195:216-226.
22. De Winter AE, Moore BD III, Slopis JM, Ater JL, Copeland DR (1999): Brain tumors in children with neurofibromatosis: Additional neuropsychological morbidity?Neuro Oncol 1:275-281.
23. Donarum EA, Halperin RF, Stephan DA, Narayanan V (2006): Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex. BMC Neurosci 7:22.
24. Dubovsky EC, Booth TN, Vezina G, Samango-Sprouse CA, Palmer KM, Brasseux CO (2001): MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1. AJNR Am J Neuroradiol 22:190-195.
25. Ecker C, Rocha-Rego V, Johnston P, Mourão-Miranda J, Marquand A, Daly EM, Brammer MJ, Murphy C, Murphy DG, MRC AIMS Consortium (2010): Investigating the predictive value of whole-brain structural MR scans in autism: A pattern classification approach. NeuroImage 49:44-56.
26. Epstein RA (2008): Parahippocampal and retrosplenial contributions to human spatial navigation. Trends Cogn Sci 12:388-396.
27. Golland P, Fischl B (2003): Permutation tests for classification: Towards statistical significance in image-based studies. Lect Notes Comput Sci 2732:330-341.
28. Greenwood RS, Tupler LA, Whitt JK, Buu A, Dombeck CB, Harp AG, Payne ME, Eastwood JD, Krishnan KRR, MacFall JR (2005): Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. Arch Neurol 62:1904-1908.
29. Gutmann DH, Geist RT, Wright DE, Snider WD (1995): Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ 6:315-323.
30. Hayasaka S, Phan KL, Liberzon I, Worsley KJ, Nichols TE (2004): Nonstationary cluster-size inference with random field and permutation methods. NeuroImage 22:676-687.
31. Hoeft F, Lightbody AA, Hazlett H, Patnaik S, Piven J, Reiss AL (2008): Morphometric spatial patterns differentiate fragile X syndrome, typical developing and developmentally delayed boys of ages one to three. Arch Gen Psychiatry 65:1087-1097.
32. Hyman SL, Shores EA, North KN (2005): The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 65:1037-1044.
33. Hyman SL, Shores EA, North KN (2006): Learning disabilities in children with neurofibromatosis type 1: Subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Dev Med Child Neurol 48:973-977.
34. Hyman SL, Gill DS, Shores EA, Steinberg A, North KN (2007): T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry 78:1088-1091.
35. Kaplan J, Meyer K (2012): Multivariate pattern analysis reveals common neural patterns across individuals during touch observation. Neuroimage 60:204-212.
36. Kaplan AM, Chen K, Lawson MA, Wodrich DL, Bonstelle CT, Reiman EM (1997): Positron emission tomography in children with neurofibromatosis-1. J Child Neurol 12:499-506.
37. Kayl AE, Moore BD III (2000): Behavioral phenotype of neurofibromatosis, type 1. Ment Retard Dev Disabil 6:117-124.
38. Kayl AE, Moore BD III, Slopis JM, Jackson EF, Leeds NE (2000): Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 15:90-96.
39. Klöppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RSJ (2008): Automatic classification of MR scans in Alzheimer's disease. Brain 131:681-689.
40. Lee DY, Yeh TH, Emnett RJ, White CR, Gutmann DH (2010): Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner. Genes Dev 24:2317-2329.
41. Levine TM, Materek A, Abel J, O'Donnell M, Cutting LE (2006): Cognitive profile of neurofibromatosis type 1. Semin Pediatr Neurol 13:8-20.
42. Makris N, Kennedy DN, McInerney S, Sorensen AG, Wang R, Caviness VS, Pandya DN (2005): Segmentation of subcomponents within the superior longitudinal fascicle in humans: A quantitative, in vivo, DT-MRI study. Cereb Cortex 15:854-869.
43. Marquand A, Howard M, Brammer M, Chu C, Coen S, Mourão-Miranda J (2010): Quantitative prediction of subjective pain intensity from whole-brain fMRI data using Gaussian processes. Neuroimage 49:2178-2189.
44. Marzelli MJ, Hoeft F, Hong DS, Reiss AL (2011): Neuroanatomical spatial patterns in Turner syndrome. NeuroImage 55:439-447.
45. Mietchen D, Gaser C (2009): Computational morphometry for detecting changes in brain structure due to development, aging, learning, disease and evolution. Front Neuroinform 3:25.
46. Moore BD III, Ater JL, Needle MN, Slopis J, Copeland DR (1994): Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol 9:368-377.
47. Moore BD III, Slopis JM, Schomer D, Jackson EF, Levy BM (1996): Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660-1668.
48. Moore BD III, Slopis JM, Jackson EF, De Winter AE, Leeds NE (2000): Brain volume in children with neurofibromatosis type 1: Relation to neuropsychological status. Neurology 54:914-920.
49. Morgado-Bernal I (2011): Learning and memory consolidation: Linking molecular and behavioral data. Neuroscience 176:12-19.
50. Neurofibromatosis.Conference statement. National Institutes of Health Consensus Development Conference (1988):Arch Neurol 45:575-578.
51. North KN (2000): Neurofibromatosis type 1. Am J Med Genet 97:119-127.
52. Park CS, Zhong L, Tang SJ (2009): Aberrant expression of synaptic plasticity-related genes in the NF1+/- mouse hippocampus. J Neurosci Res 87:3107-3119.
53. Payne JM, Moharir MD, Webster R, North KN (2010): Brain structure and function in neurofibromatosis type 1: Current concepts and future directions. J Neurol Neurosurg Psychiatry 81:304-309.
54. Pereira F, Botvinick M (2011): Information mapping with pattern classifiers: A comparative study. Neuroimage 56:476-496.
55. Pereira F, Mitchell T, Botvinick M (2009): Machine learning classifiers and fMRI: A tutorial overview. NeuroImage 45:S199-S209.
56. Pride N, Payne JM, Webster R, Shores EA, Rae C, North KN (2010): Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1. J Child Neurol 25:834-841.
57. Puttemans V, Wenderoth N, Swinnen SP (2005): Changes in brain activation during the acquisition of a multifrequency bimanual coordination task: From the cognitive stage to advanced levels of automaticity. J Neurosci 25:4270-4278.
58. Raven JC (1947): Raven's Advanced Progressive Matrices APM Set I.Oxford:Oxford Psychologists Press.
59. Ribeiro MJ, Violante IR, Bernardino I, Ramos F, Saraiva J, Reviriego P, Upadhyaya M, Silva ED, Castelo-Branco M (2012): Abnormal achromatic and chromatic contrast sensitivity in neurofibromatosis type 1. Invest Ophthalmol Vis Sci 53:287-293.
60. Roy A, Roulin JL, Charbonnier V, Allain P, Fasotti L, Barbarot S, Stalder JF, Terrien A, Gall DL (2010): Executive dysfunction in children with neurofibromatosis type 1: A study of action planning. J Int Neuropsychol Soc 16:1056-1063.
61. Schrimsher GW, Billingsley RL, Slopis JM, Moore BD III (2003): Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet A 120:326-330.
62. Seghier ML, Fagan E, Price CJ (2010): Functional subdivisions in the left angular gyrus where the semantic system meets and diverges from the default network. J Neurosci 30:16809-16817.
63. Smith AT, Cotton PL, Bruno A, Moutsiana C (2009): Dissociating vision and visual attention in the human pulvinar. J Neurophysiol 101:917-925.
64. Steen RG, Taylor JS, Langston JW, Glass JO, Brewer VR, Reddick WE, Mages R, Pivnick EK (2001): Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: Relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. AJNR Am J Neuroradiol 22:810-817.
65. Tonsgard JH (2006): Clinical manifestations and management of neurofibromatosis type 1. Semin Pediatr Neurol 13:2-7.
66. Wakana S, Jiang H, van Zijl PCM, Mori S (2004): Fiber tract-based atlas of human white matter anatomy. Radiology 230:77-87.
67. Wang PY, Kaufmann WE, Koth CW, Denckla MB, Barker PB (2000): Thalamic involvement in neurofibromatosis type 1: Evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol 47:477-484.
68. Wechsler D (2003): Escala de Inteligência de Wechsler para Crianças-Terceira Edição (WISC-III): Manual.Lisboa:CEGOC-Tea.
69. Wignall EL, Griffiths PD, Papadakis NG, Wilkinson ID, Wallis LI, Bandmann O, Cowell PEE, Hoggard N (2010): Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: Initial findings in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol 31:856-861.
70. Wilke M, Holland SK, Altaye M, Gaser C (2008): Template-O-Matic: A toolbox for creating customized pediatric templates. NeuroImage 41:903-913.
71. Worsley KJ, Andermann M, Koulis T, MacDonald D, Evans AC (1999): Detecting changes in nonisotropic images. Hum Brain Mapp 8:98-101.
72. Yokota O, Tsuchiya K, Hayashi M, Kakita A, Ohwada K, Ishizu H, Takahashi H, Akiyama H (2008): Glial clusters and perineuronal glial satellitosis in the basal ganglia of neurofibromatosis type 1. Acta Neuropathol 116:57-66.
73. Zamboni SL, Loenneker T, Boltshauser E, Martin E, Il'yasov KA (2007): Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol 28:773-776.
74. Zhu Y, Harada T, Liu L, Lush ME, Guignard F, Harada C, Burns DK, Bajenaru ML, Gutmann DH, Parada LF (2005): Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development 132:5577-5588.